4519 — Chugai Pharmaceutical Share News
0.000.00%
Last trade - 00:00Will Build New Laboratory Building To Strengthen Manufacturing Process Development Capabilities And Advance Environmental Initiatives
Table: Chugai Pharm 6-MTH group results (IFRS)
Table: Chugai Pharm -Q1 group results (IFRS)
Roche seeks US tariff relief in direct talks with Trump administration (updated)
Roche: U.S. investment plans will not be at expense of other parts of world
Table: Chugai Pharm -2024 group results (IFRS)
Table: Chugai Pharm -9-MTH group results (IFRS)
Table: Chugai Pharm -Q1 group results (IFRS)
Japan's Nikkei slips on caution ahead of US inflation data
Immunovant and Argenx rise as rival Chugai's data fails to impress
Eli Lilly And Company Disclose Form 10-K Including Orforglipron Related Information
Table: Chugai Pharm -2023 group results (IFRS)
Shanghai Pharmaceuticals falls on fine for violating anti-monopoly law
Table: Chugai Pharm -9-MTH group results (IFRS)
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug
Table: Chugai Pharm -6-MTH group results (IFRS)
Chugai Files Patent Infringement Lawsuit Against Biogen Ma Inc. And Bio-Thera Solutions, Ltd. In U.S
Chugai Files New Drug Application In Japan For Crovalimab For Paroxysmal Nocturnal Hemoglobinuria
Table: Chugai Pharm -Q1 group results (IFRS)